UPDATE : Saturday, February 22, 2020
상단여백
CancerRop advances into Malaysian gene market by Lee Han-soo 2018-10-24 17:49
Celltrion releases clinical trial results for Remsima SC in EU and US by Lee Han-soo 2018-10-24 16:47
Will synthetic biology be vital in smart therapeutics? by Nam Doo-hyun 2018-10-24 16:40
Biotech shares tank amid nosediving of Seoul stocks by Nam Doo-hyun 2018-10-24 11:35
‘Antibody drug developer AbClon noteworthy’ by Nam Doo-hyun 2018-10-22 14:49
라인
L&C BIO sets offering price at ₩24,000 for KOSDAQ debut by So Jae-hyeon 2018-10-22 14:12
'Superbug' fears bring antibiotics developers under spotlight by Nam Doo-hyun 2018-10-22 11:53
Celltrion, Samsung BioLogics named Fortune’s ‘Future 50’ by Lee Han-soo 2018-10-19 16:34
CancerRop launches unit to develop cell therapies by Lee Han-soo 2018-10-18 15:25
Biogen, Samsung Bioepis announce European launch of Imraldi by Lee Han-soo 2018-10-17 17:28
라인
Bio stocks listed under ‘tech exception policy’ perform better by Nam Doo-hyun 2018-10-15 12:27
Merck to supply Samsung’s biosimilar to US Veterans Affairs Dept. by Lee Han-soo 2018-10-11 16:31
US drug advisory recommends Celltrion’s Rituxan biosimilar for approval by Lee Han-soo 2018-10-11 12:10
‘Korea publishes many biotech papers but rarely links them to biz’ by Nam Doo-hyun 2018-10-10 16:35
GC opens new cell research center by Lee Han-soo 2018-10-10 11:45
라인
More biotech stocks come in top 20 on KOSDAQ by Nam Doo-hyun 2018-10-10 11:20
Newly listed biotech firms perform poorly on KOSDAQ by Nam Doo-hyun 2018-10-04 13:09
‘Samsung C&T’s value to rise on BioLogics’ increased value’ by Nam Doo-hyun 2018-10-03 10:11
More doctoral degree holders wanted at biotech ventures by Nam Doo-hyun 2018-10-02 14:40
FDA to review Samsung Bioepis’ application for anti-arthritis biosimilar by Lee Han-soo 2018-09-27 11:22
여백
여백
여백
Back to Top